New York based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to New York-based Synergy Pharmaceuticals, Inc., a biopharmaceutical company focused primarily on the …
Sichenzia Ross Friedman Ference LLP Advises Synergy Pharmaceuticals, Inc. on $103 Million Public Offering.
New York based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to New York-based Synergy Pharmaceuticals, Inc., a biopharmaceutical company focused primarily on the …
Sichenzia Ross Friedman Ference LLP To Sponsor the 25th Annual Roth OC Conference from March 17th – 20th in Dana Point, CA
New York, NY (March 13, 2013) – Sichenzia Ross Friedman Ference LLP (SRFF) today announced its participation as a Silver Sponsor for the 25th Annual Roth OC Conference to be held at the Ritz Carlton …
Sichenzia Ross Friedman Ference LLP Advises DelMar Pharmaceuticals, Inc. on $10.5M Reverse Merger and Financing
Sichenzia Ross Friedman Ference LLP Advises DelMar Pharmaceuticals, Inc. on $10.5M Reverse Merger and Financing NEW YORK, March 6, 2013 (GLOBE NEWSWIRE) -- New York- based securities law firm, …
5 Reasons Why Equity-Based Crowdfunding Under the JOBS Act Won’t Work
There's so much hype surrounding crowdfunding and for good reason. Stories like the one of Ouya, a game console developer that raised $950,000 in just 8 hours on Kickstarter capture our imaginations. …
Continue Reading about 5 Reasons Why Equity-Based Crowdfunding Under the JOBS Act Won’t Work →
Jeffrey Fessler Attends the NASDAQ Opening Bell Ringing with Northwest Biotherapeutics, Inc. (NWBO)
Northwest Biotherapeutics, Inc.visits the NASDAQ Stock Market to celebrate its recent listing on NASDAQ . In honor of the occasion, CEO Linda Powers rings the opening bell, joined other company …
